Status:
RECRUITING
BJH-SDS Validation of the German Translation
Lead Sponsor:
University of Giessen
Conditions:
Dysphagia
Stroke, Acute
Eligibility:
All Genders
18-100 years
Brief Summary
The first object of the study is the validation of a translation of the Barnes-Jewish Hospital Stroke Dysphagia Screen with determination of sensitivity, specificity, interrater reliability (especiall...
Detailed Description
Stroke is now the second most common cause of death worldwide. Dysphagia is described as a direct consequence of cerebral infarction in at least 50% of stroke patients in the acute phase \[2\]. It oft...
Eligibility Criteria
Inclusion
- All stroke patients in the neurology department of the Lahn-Dill Clinic in Wetzlar and the stroke unit of the Bürgerhospital in Friedberg and the neurologic ICU of the University Hospital in Giessen are to be screened with the BJH-SDS-G after appropriate information has been provided.
Exclusion
- Exclusion criteria are a lack of informed consent, contraindications to an FEES examination, a history of stroke, pre-existing dysphagia or a disease that may be associated with dysphagia (e.g. ENT tumors, Parkinson's disease, neuromuscular diseases).
Key Trial Info
Start Date :
April 15 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
570 Patients enrolled
Trial Details
Trial ID
NCT06497790
Start Date
April 15 2024
End Date
May 1 2026
Last Update
July 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Giessen and Marburg, Campus Giessen
Giesen, Hesse, Germany, 35392